IN2014CN02680A - - Google Patents
Info
- Publication number
- IN2014CN02680A IN2014CN02680A IN2680CHN2014A IN2014CN02680A IN 2014CN02680 A IN2014CN02680 A IN 2014CN02680A IN 2680CHN2014 A IN2680CHN2014 A IN 2680CHN2014A IN 2014CN02680 A IN2014CN02680 A IN 2014CN02680A
- Authority
- IN
- India
- Prior art keywords
- membered
- 1compound
- mixtures
- indicates
- preventing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161537062P | 2011-09-21 | 2011-09-21 | |
| US201261614965P | 2012-03-23 | 2012-03-23 | |
| PCT/IL2012/050381 WO2013042124A1 (en) | 2011-09-21 | 2012-09-20 | Use of strigolactones and strigolactone analogs for treating proliferative conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN02680A true IN2014CN02680A (cg-RX-API-DMAC7.html) | 2015-07-03 |
Family
ID=47913975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2680CHN2014 IN2014CN02680A (cg-RX-API-DMAC7.html) | 2011-09-21 | 2012-09-20 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10208007B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2758392B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014527979A (cg-RX-API-DMAC7.html) |
| CN (1) | CN104053655A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2849343C (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014CN02680A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013042124A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11458154B2 (en) | 2013-09-06 | 2022-10-04 | Vanda Pharmaceuticals Inc. | Treatment of CYR61- and VEGF-mediated conditions |
| US20180235213A1 (en) * | 2015-05-14 | 2018-08-23 | The State of Israel Ministry of Agriculture & Rural Develop. Agricultural Research Organization | Plant hormone application |
| GB201615544D0 (en) * | 2016-09-13 | 2016-10-26 | Syngenta Participations Ag | Plant Growth regulator compounds |
| CN108558796B (zh) * | 2018-05-07 | 2020-04-07 | 南开大学 | 一类羟亚甲基氢化茚酮衍生物及其制备方法和用途 |
| CN108675974B (zh) * | 2018-05-07 | 2020-04-07 | 南开大学 | 一类独脚金内酯衍生物及其制备方法和用途 |
| EP3876927A1 (en) * | 2018-11-08 | 2021-09-15 | Universita' Degli Studi di Torino | Strigolactones for use in preventing and/or treating infections caused by viruses of the herpesviridae family |
| CN117843651B (zh) * | 2024-01-03 | 2024-09-10 | 盐城工学院 | 一种含有三氟甲基季碳中心的四氢呋喃并[3,2-b]吲哚啉类化合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2865897B1 (fr) | 2004-02-10 | 2006-06-09 | Univ Toulouse | Modulateurs de developpement des champignons mycorhiziens a arbuscules, et applications. |
| TW200904330A (en) | 2007-06-15 | 2009-02-01 | Bayer Cropscience Sa | Pesticidal composition comprising a strigolactone derivative and a fungicide compound |
| TW200904331A (en) | 2007-06-15 | 2009-02-01 | Bayer Cropscience Sa | Pesticidal composition comprising a strigolactone derivative and an insecticide compound |
| EP2248421A1 (en) | 2009-05-07 | 2010-11-10 | GMI - Gregor-Mendel-Institut für Molekulare Pflanzenbiologie GmbH | Accumulation of biomass in plants |
| FI20106119A0 (fi) | 2010-10-27 | 2010-10-27 | Sirtuin Valley Oy | Energia-aineenvaihduntaan vaikuttava koostumus |
-
2012
- 2012-09-20 WO PCT/IL2012/050381 patent/WO2013042124A1/en not_active Ceased
- 2012-09-20 US US14/345,371 patent/US10208007B2/en not_active Expired - Fee Related
- 2012-09-20 CA CA2849343A patent/CA2849343C/en not_active Expired - Fee Related
- 2012-09-20 CN CN201280054089.9A patent/CN104053655A/zh active Pending
- 2012-09-20 IN IN2680CHN2014 patent/IN2014CN02680A/en unknown
- 2012-09-20 JP JP2014531375A patent/JP2014527979A/ja active Pending
- 2012-09-20 EP EP12833721.9A patent/EP2758392B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| CA2849343A1 (en) | 2013-03-28 |
| CN104053655A (zh) | 2014-09-17 |
| US10208007B2 (en) | 2019-02-19 |
| EP2758392B1 (en) | 2019-09-18 |
| EP2758392A4 (en) | 2015-05-20 |
| EP2758392A1 (en) | 2014-07-30 |
| US20140323563A1 (en) | 2014-10-30 |
| CA2849343C (en) | 2020-12-15 |
| WO2013042124A8 (en) | 2013-07-25 |
| WO2013042124A1 (en) | 2013-03-28 |
| JP2014527979A (ja) | 2014-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN02680A (cg-RX-API-DMAC7.html) | ||
| UY39630A (es) | Inhibidores de bromodominios | |
| MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
| MY196383A (en) | Benzo[B]Thiophene Compounds As Sting Agonists | |
| MX2019003468A (es) | Derivados de tieno [3,2-d]pirimidina que tienen actividad inhibidora de las cinasas de proteina. | |
| PH12016500024A1 (en) | Bromodomain inhibitor | |
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| SA515360469B1 (ar) | مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها | |
| MX394360B (es) | Inhibidores de jak2 y alk2 y metodos para su uso. | |
| MY197785A (en) | Combinations of lsd1 inhibitors for the treatment of hematological malignancies | |
| PH12013502112A1 (en) | Amide compound and pharmaceutical application therefor | |
| CO6741203A2 (es) | Derivados de biciclo[3,2,1]octilamida y sus usos | |
| TN2012000533A1 (en) | New forms of rifaximin and uses thereof | |
| DOP2014000081A (es) | Compuestos y procedimientos para mejorar las respuestas inmunitarias innatas | |
| UY34775A (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis múltiple | |
| IN2014DN06869A (cg-RX-API-DMAC7.html) | ||
| WO2014062838A3 (en) | Pkm2 modulators and methods for their use | |
| PH12015501386A1 (en) | Tricyclic compounds | |
| MX373389B (es) | Derivado de sulfonamida y uso farmaceutico del mismo. | |
| WO2014153495A9 (en) | Novel stat3 inhibitors | |
| MX363699B (es) | Producto de comicronizacion que comprende acetato de ulipristal. | |
| DOP2013000305A (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
| MY173564A (en) | Cxcr7 receptor modulators | |
| MX2014013664A (es) | N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxietil)ami no)-2-oxo-n-fenil-1,2-dihidroquinolin-3-carboxamida. | |
| MX368635B (es) | Compuestos tricíclicos de piperidina. |